PGR
68
3
FCX
57
-2
HOG
36
-3
PSA
63
2
NOV
55
-4
OI
38
-5
KSS
26
-15
CI
63
7
AZO
53
3
SWKS
51
-2
GM
65
-7
INTU
56
3
IRM
52
2
INTC
40
-4
ZTS
47
-9
OKE
78
3
NTAP
73
6
ROK
64
-2
OXY
37
-3
SPG
63
7
PGR
68
3
FCX
57
-2
HOG
36
-3
PSA
63
2
NOV
55
-4
OI
38
-5
KSS
26
-15
CI
63
7
AZO
53
3
SWKS
51
-2
GM
65
-7
INTU
56
3
IRM
52
2
INTC
40
-4
ZTS
47
-9
OKE
78
3
NTAP
73
6
ROK
64
-2
OXY
37
-3
SPG
63
7
Financhill
Back

Fomento de Construcciones y Contratas SA Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

FMOCF
Fomento de Construcciones y Contratas SA

Last Price:
10.61
Seasonality Move:
9.84%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
134.73
Seasonality Move:
14.88%
Sell
45
Fomento de Construcciones y Contratas SA (FMOCF) is a Sell

Is Fomento de Construcciones y Contratas SA a Buy, Sell or Hold?

  • The current Fomento de Construcciones y Contratas SA [FMOCF] share price is $10.61. The Score for FMOCF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • FMOCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FMOCF Stock Price Chart

What is Fomento de Construcciones y Contratas SA's stock price today?

  • The Fomento de Construcciones y Contratas SA share price today is $10.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMOCF is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FMOCF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.2 Sell
Relative Strength Index (14 RSI): 0.01 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 15.31) Sell
Bollinger Bands (100): (13.18 - 15.96) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

FMOCF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.61 Sell
20-day SMA: 12.61 Sell
50-day SMA: 14.08 Sell
200-day SMA: 14.29 Sell
8-day EMA: 10.89 Sell
20-day EMA: 12.09 Sell
50-day EMA: 13.46 Sell
200-day EMA: 13.78 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Fomento de Construcciones y Contratas SA Earnings Growth & FMOCF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Fomento de Construcciones y Contratas SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):